The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
After a slow couple of weeks, the biotech IPO market is heating back up with four more companies hitting Nasdaq.
Instil Bio, Connect Biopharma, Finch Therapeutics and Gain Therapeutics are this week’s winners, with the fearsome foursome all making their public debuts Thursday or Friday. Instil led the way with a heavily upsized $320 million raise, marking the second-biggest IPO raise of 2021 behind Sana, and Connect and Finch also pulled in nine-figure funding.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.